Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Intravenous or Subcutaneous Methoxy Polyethylene Glycol-Epoetin Beta (RO0503821, Mircera) in Chronic Kidney Disease Patients With Renal Anemia

ClinicalTrials.gov ID: NCT00090753

Public ClinicalTrials.gov record NCT00090753. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 11:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Multi-center Study to Document the Efficacy, Safety, and Tolerability of Long-term Administration of RO0503821 in Patients With Chronic Renal Anemia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study assessed the long-term efficacy, safety, and tolerability of intravenous (iv) or subcutaneous (sc) methoxy polyethylene glycol-epoetin beta in chronic kidney disease patients with renal anemia. Eligible patients were those who were receiving stable maintenance therapy with methoxy polyethylene glycol-epoetin beta or erythropoiesis stimulating agents (ESAs) in Phase II or III clinical studies. They continued to receive methoxy polyethylene glycol-epoetin beta or comparator ESAs at the same weekly dose and by the same route of administration (sc or iv) as in the qualifying studies.

Study identification

NCT ID
NCT00090753
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
1,228 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2004 (Type not available)
Primary completion
Dec 2009 (Actual)
Completion
Dec 2009 (Actual)
Last update posted
Feb 14, 2012

2004 – 2009

United States locations

U.S. sites
83
U.S. states
29
U.S. cities
72
Facility City State ZIP Site status
Not listed Birmingham Alabama 35211 —
Not listed Mobile Alabama 36608 —
Not listed Montgomery Alabama 36106 —
Not listed Hot Springs Arkansas 71901 —
Not listed Covina California 91723 —
Not listed Encino California 91356 —
Not listed Irvine California 92868 —
Not listed Los Alamitos California 90720 —
Not listed Los Angeles California 90073 —
Not listed Los Angeles California 90095 —
Not listed Monterey Park California 91754 —
Not listed Mountain View California 94040 —
Not listed Sacramento California 95816-5119 —
Not listed San Diego California 92120 —
Not listed San Diego California 92123 —
Not listed San Francisco California 94117 —
Not listed Stanford California 94305 —
Not listed Colorado Springs Colorado 80909 —
Not listed Denver Colorado 80262 —
Not listed Lakewood Colorado 80260 —
Not listed Stamford Connecticut 06902 —
Not listed Ocala Florida 34471 —
Not listed Pembroke Pines Florida 33028 —
Not listed Atlanta Georgia 30342 —
Not listed Augusta Georgia 30309 —
Not listed Honolulu Hawaii 96813 —
Not listed Maywood Illinois 60153 —
Not listed South Holland Illinois 60473 —
Not listed Louisville Kentucky 40202-1718 —
Not listed Baton Rouge Louisiana 70884 —
Not listed Shreveport Louisiana 71101 —
Not listed Boston Massachusetts 02115 —
Not listed Boston Massachusetts 02135 —
Not listed Springfield Massachusetts 01107 —
Not listed Detroit Michigan 48202-2689 —
Not listed Detroit Michigan 48236 —
Not listed Kalamazoo Michigan 49007 —
Not listed Brooklyn Center Minnesota 55430 —
Not listed Columbus Mississippi 39705 —
Not listed Tupelo Mississippi 38801 —
Not listed St Louis Missouri 63110 —
Not listed Hackensack New Jersey 07601 —
Not listed Paterson New Jersey 07503 —
Not listed Albuquerque New Mexico 87131 —
Not listed Brooklyn New York 11203 —
Not listed Flushing New York 11355 —
Not listed Great Neck New York 11021 —
Not listed Mineola New York 11501 —
Not listed New York New York 10021 —
Not listed New York New York 10128 —
Not listed Orchard Park New York 14127 —
Not listed The Bronx New York 10467 —
Not listed Chapel Hill North Carolina 27599-7155 —
Not listed Mount Airy North Carolina 27030 —
Not listed Raleigh North Carolina 27609 —
Not listed Cincinnati Ohio 45267-0585 —
Not listed Cleveland Ohio 44109 —
Not listed Toledo Ohio 43606 —
Not listed Oregon City Oregon 97045 —
Not listed Portland Oregon 97201-2940 —
Not listed Portland Oregon 97210 —
Not listed Allentown Pennsylvania 18103 —
Not listed Erie Pennsylvania 16502 —
Not listed Lewistown Pennsylvania 17044 —
Not listed Philadelphia Pennsylvania 19106 —
Not listed Philadelphia Pennsylvania 19140 —
Not listed Philadelphia Pennsylvania 19141 —
Not listed Pittsburgh Pennsylvania 15224 —
Not listed Columbia South Carolina 29209 —
Not listed Orangeburg South Carolina 29118 —
Not listed Chattanooga Tennessee 37404 —
Not listed Nashville Tennessee 37205 —
Not listed Nashville Tennessee 37232 —
Not listed Austin Texas 78758 —
Not listed Dallas Texas 75216 —
Not listed Houston Texas 77030 —
Not listed Houston Texas 77054 —
Not listed Houston Texas 77099 —
Not listed Burlington Vermont 05401 —
Not listed Fairfax Virginia 22031 —
Not listed Norfolk Virginia 23507-1901 —
Not listed Salem Virginia 24153 —
Not listed Morgantown West Virginia 26506 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 166 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00090753, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 14, 2012 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00090753 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →